Search results
Results from the WOW.Com Content Network
Titan Company commenced operations in 1984 under the name Titan Watches Limited. In 1994, Titan diversified into jewellery with Tanishq and subsequently into eyewear with Titan Eyeplus. In 2005, it launched its youth fashion accessories brand Fastrack. [7] Titan is the largest branded jewellery maker in India by value, with a 6% market share as ...
Titan was hired by the US military in 2003 to provide translation services, receiving $112.1 million. This accounted for 6 percent of its total revenue for 2003, according to its annual report. [2] The company had 12,000 employees worldwide, with annual revenues in the neighborhood of $2 billion and was traded on the NYSE as TTN. [citation needed]
Titan International (TWI) delivers y/y improvement in Q4 earnings and revenues, courtesy of strong demand. It expects to deliver revenues of more than $2 billion in 2022.
By the end of the 1980s, Titan launched Tanishq, which focused largely on exports to European and American markets, in an attempt to increase its foreign exchange reserves. In the early 1990s, India's exchange crisis was resolved, and Titan Company shifted the focus of the brand to the Indian market.
In 2010, Titan purchased the assets of Leavittsburg, Ohio based Denman Tire in bankruptcy court for US$4.4 million. [5] This purchase includes the consumer-related tires (on-road) as well, which Titan is considering to divest. [6] [7] In November 2011, Titan Purchased Goodyear's Union City, Tennessee plant four months after Goodyear closed it ...
In 2017, Iconix sold Badgley Mischka to Mark Badgley, James Mischka, and Titan Industries for $16 million in cash. [12] [13] Still in 2017, the label launched its home furnishings collection. [14] In 2018, the label signed a beauty license with TPR Holdings LLC. [15] In 2024, the label launched its first fragrances. [16]
Atlas Air Worldwide Reports Fourth-Quarter and Full-Year 2012 Earnings 4Q12 Adjusted Net Income Up 23% to $48.7 Million, $1.83 per Share Full-Year Adjusted Net Income Rose 17% to $127.0 Million ...
Titan Pharmaceuticals, Inc. is a biopharmaceutical company based in San Francisco, CA, developing proprietary therapeutics primarily for treating central nervous system ("CNS") disorders. In September 2018, Titan Pharmaceuticals underwent an IPO wherein it raised $9.5 million in gross proceeds. [ 3 ]